{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T09:26:35Z","timestamp":1793870795413,"version":"4.6.1"},"reference-count":75,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,11,30]],"date-time":"2023-11-30T00:00:00Z","timestamp":1701302400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,11,30]],"date-time":"2023-11-30T00:00:00Z","timestamp":1701302400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000060","name":"U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R01 AI048638"],"award-info":[{"award-number":["R01 AI048638"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Immunol"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1038\/s41590-023-01700-0","type":"journal-article","created":{"date-parts":[[2023,11,30]],"date-time":"2023-11-30T17:01:49Z","timestamp":1701363709000},"page":"41-53","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":98,"title":["BCG vaccination stimulates integrated organ immunity by feedback of the adaptive immune response to imprint prolonged innate antiviral resistance"],"prefix":"10.1038","volume":"25","author":[{"given":"Audrey","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0866-6961","authenticated-orcid":false,"given":"Katharine","family":"Floyd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengyang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7418-1313","authenticated-orcid":false,"given":"Zhuoqing","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tze Kai","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather M.","family":"Froggatt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John M.","family":"Powers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4989-5381","authenticated-orcid":false,"given":"Sarah R.","family":"Leist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kendra L.","family":"Gully","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miranda L.","family":"Hubbard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunfeng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harold","family":"Hui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Scoville","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alistaire D.","family":"Ruggiero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8536-5951","authenticated-orcid":false,"given":"Yan","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Pavenko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor","family":"Lujan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6827-8701","authenticated-orcid":false,"given":"Ralph S.","family":"Baric","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8862-9043","authenticated-orcid":false,"given":"Garry P.","family":"Nolan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0090-5689","authenticated-orcid":false,"given":"Prabhu S.","family":"Arunachalam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehul S.","family":"Suthar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6517-4333","authenticated-orcid":false,"given":"Bali","family":"Pulendran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,11,30]]},"reference":[{"key":"1700_CR1","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1038\/ni.2039","volume":"12","author":"B Pulendran","year":"2011","unstructured":"Pulendran, B. & Ahmed, R. Immunological mechanisms of vaccination. Nat. Immunol. 12, 509\u2013517 (2011).","journal-title":"Nat. Immunol."},{"key":"1700_CR2","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1136\/bmj.311.7003.481","volume":"311","author":"P Aaby","year":"1995","unstructured":"Aaby, P. et al. Non-specific beneficial effect of measles immunisation: analysis of mortality studies from developing countries. BMJ 311, 481 (1995).","journal-title":"BMJ"},{"key":"1700_CR3","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1093\/infdis\/jir240","volume":"204","author":"P Aaby","year":"2011","unstructured":"Aaby, P. et al. Randomized trial of BCG vaccination at birth to low-birth-weight children: beneficial nonspecific effects in the neonatal period? J. Infect. Dis. 204, 245\u2013252 (2011).","journal-title":"J. Infect. Dis."},{"key":"1700_CR4","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.1093\/cid\/civ617","volume":"61","author":"N Lund","year":"2015","unstructured":"Lund, N. et al. The effect of oral polio vaccine at birth on infant mortality: a randomized trial. Clin. Infect. Dis. 61, 1504\u20131511 (2015).","journal-title":"Clin. Infect. Dis."},{"key":"1700_CR5","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1016\/j.cmi.2019.04.020","volume":"25","author":"SJCFM Moorlag","year":"2019","unstructured":"Moorlag, S. J. C. F. M., Arts, R. J. W., van Crevel, R. & Netea, M. G. Non-specific effects of BCG vaccine on viral infections. Clin. Microbiol. Infect. 25, 1473\u20131478 (2019).","journal-title":"Clin. Microbiol. Infect."},{"key":"1700_CR6","doi-asserted-by":"publisher","first-page":"100728","DOI":"10.1016\/j.xcrm.2022.100728","volume":"3","author":"DL Faustman","year":"2022","unstructured":"Faustman, D. L. et al. Multiple BCG vaccinations for the prevention of COVID-19 and other infectious diseases in type 1 diabetes. Cell Rep. Med. 3, 100728 (2022).","journal-title":"Cell Rep. Med."},{"key":"1700_CR7","doi-asserted-by":"publisher","first-page":"e20211862","DOI":"10.1084\/jem.20211862","volume":"219","author":"KL Hilligan","year":"2021","unstructured":"Hilligan, K. L. et al. Intravenous administration of BCG protects mice against lethal SARS-CoV-2 challenge. J. Exp. Med 219, e20211862 (2021).","journal-title":"J. Exp. Med"},{"key":"1700_CR8","doi-asserted-by":"publisher","first-page":"17720","DOI":"10.1073\/pnas.2008410117","volume":"117","author":"LE Escobar","year":"2020","unstructured":"Escobar, L. E., Molina-Cruz, A. & Barillas-Mury, C. BCG vaccine protection from severe coronavirus disease 2019 (COVID-19). Proc. Natl Acad. Sci. USA 117, 17720\u201317726 (2020).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1700_CR9","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1038\/s41577-020-0337-y","volume":"20","author":"LAJ O\u2019Neill","year":"2020","unstructured":"O\u2019Neill, L. A. J. & Netea, M. G. BCG-induced trained immunity: can it offer protection against COVID-19? Nat. Rev. Immunol. 20, 335\u2013337 (2020).","journal-title":"Nat. Rev. Immunol."},{"key":"1700_CR10","doi-asserted-by":"publisher","first-page":"18377","DOI":"10.1038\/s41598-020-75491-x","volume":"10","author":"J Hensel","year":"2020","unstructured":"Hensel, J. et al. Protection against SARS-CoV-2 by BCG vaccination is not supported by epidemiological analyses. Sci. Rep. 10, 18377 (2020).","journal-title":"Sci. Rep."},{"key":"1700_CR11","doi-asserted-by":"publisher","first-page":"110502","DOI":"10.1016\/j.celrep.2022.110502","volume":"38","author":"E Kaufmann","year":"2022","unstructured":"Kaufmann, E. et al. BCG vaccination provides protection against IAV but not SARS-CoV-2. Cell Rep. 38, 110502 (2022).","journal-title":"Cell Rep."},{"key":"1700_CR12","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.1056\/NEJMoa2212616","volume":"388","author":"LF Pittet","year":"2023","unstructured":"Pittet, L. F. et al. Randomized trial of BCG vaccine to protect against Covid-19 in health care workers. N. Engl. J. Med. 388, 1582\u20131596 (2023).","journal-title":"N. Engl. J. Med."},{"key":"1700_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.chom.2023.05.006","volume":"31","author":"PA Darrah","year":"2023","unstructured":"Darrah, P. A. et al. Article airway T cells are a correlate of i.v. Bacille Calmette\u2013Guerin-mediated protection against tuberculosis in rhesus macaques. Cell Host Microbe 31, 1\u201316 (2023).","journal-title":"Cell Host Microbe"},{"key":"1700_CR14","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1038\/s41591-018-0319-9","volume":"25","author":"K Dijkman","year":"2019","unstructured":"Dijkman, K. et al. Prevention of tuberculosis infection and disease by local BCG in repeatedly exposed rhesus macaques. Nat. Med. 25, 255\u2013262 (2019).","journal-title":"Nat. Med."},{"key":"1700_CR15","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.smim.2013.04.006","volume":"25","author":"SHE Kaufmann","year":"2013","unstructured":"Kaufmann, S. H. E. Tuberculosis vaccines: time to think about the next generation. Semin. Immunol. 25, 172\u2013181 (2013).","journal-title":"Semin. Immunol."},{"key":"1700_CR16","doi-asserted-by":"publisher","first-page":"4689","DOI":"10.4049\/jimmunol.171.9.4689","volume":"171","author":"SC Cowley","year":"2003","unstructured":"Cowley, S. C. & Elkins, K. L. CD4+ T cells mediate IFN-independent control of Mycobacterium tuberculosis infection both in vitro and in vivo tuberculosis. J. Immunol. 171, 4689\u20134699 (2003).","journal-title":"J. Immunol."},{"key":"1700_CR17","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1164\/rccm.201003-0334OC","volume":"182","author":"BMN Kagina","year":"2010","unstructured":"Kagina, B. M. N. et al. Specific T cell frequency and cytokine expression profile do not correlate with protection against tuberculosis after bacillus Calmette\u2013Gu\u00e9rin vaccination of newborns. Am. J. Respir. Crit. Care Med. 182, 1073\u20131079 (2010).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"1700_CR18","doi-asserted-by":"publisher","first-page":"12434","DOI":"10.1073\/pnas.0703510104","volume":"104","author":"HW Mittr\u00fccker","year":"2007","unstructured":"Mittr\u00fccker, H. W. et al. Poor correlation between BCG vaccination-induced T cell responses and protection against tuberculosis. Proc. Natl Acad. Sci. USA 104, 12434\u201312439 (2007).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1700_CR19","doi-asserted-by":"publisher","first-page":"eabc2934","DOI":"10.1126\/sciimmunol.abc2934","volume":"6","author":"E Mata","year":"2021","unstructured":"Mata, E. et al. Pulmonary BCG induces lung-resident macrophage activation and confers long-term protection against tuberculosis. Sci. Immunol. 6, eabc2934 (2021).","journal-title":"Sci. Immunol."},{"key":"1700_CR20","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1111\/imcb.12278","volume":"97","author":"P Steigler","year":"2019","unstructured":"Steigler, P., Verrall, A. J. & Kirman, J. R. Beyond memory T cells: mechanisms of protective immunity to tuberculosis infection. Immunol. Cell Biol. 97, 647\u2013655 (2019).","journal-title":"Immunol. Cell Biol."},{"key":"1700_CR21","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1038\/s41577-020-0285-6","volume":"20","author":"MG Netea","year":"2020","unstructured":"Netea, M. G. et al. Defining trained immunity and its role in health and disease. Nat. Rev. Immunol. 20, 375\u2013388 (2020).","journal-title":"Nat. Rev. Immunol."},{"key":"1700_CR22","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.smim.2016.09.002","volume":"28","author":"RJW Arts","year":"2016","unstructured":"Arts, R. J. W., Joosten, L. A. B. & Netea, M. G. Immunometabolic circuits in trained immunity. Semin. Immunol. 28, 425\u2013430 (2016).","journal-title":"Semin. Immunol."},{"key":"1700_CR23","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1016\/j.chom.2020.05.014","volume":"28","author":"B Cirovic","year":"2020","unstructured":"Cirovic, B. et al. BCG vaccination in humans elicits trained immunity via the hematopoietic progenitor compartment. Cell Host Microbe 28, 322\u2013334.e5 (2020).","journal-title":"Cell Host Microbe"},{"key":"1700_CR24","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1159\/000355628","volume":"6","author":"J Kleinnijenhuis","year":"2014","unstructured":"Kleinnijenhuis, J. et al. Long-lasting effects of bcg vaccination on both heterologous Th1\/Th17 responses and innate trained immunity. J. Innate Immun. 6, 152\u2013158 (2014).","journal-title":"J. Innate Immun."},{"key":"1700_CR25","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.cell.2017.12.031","volume":"172","author":"E Kaufmann","year":"2018","unstructured":"Kaufmann, E. et al. BCG educates hematopoietic stem cells to generate protective innate immunity against tuberculosis. Cell 172, 176\u2013190.e19 (2018).","journal-title":"Cell"},{"key":"1700_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.chom.2017.12.010","author":"RJW Arts","year":"2018","unstructured":"Arts, R. J. W. et al. BCG vaccination protects against experimental viral infection in humans through the induction of cytokines associated with trained immunity. Cell Host Microbe https:\/\/doi.org\/10.1016\/j.chom.2017.12.010 (2018).","journal-title":"Cell Host Microbe"},{"key":"1700_CR27","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1202870109","author":"J Kleinnijenhuis","year":"2012","unstructured":"Kleinnijenhuis, J. et al. Bacille Calmette\u2013Guerin induces NOD2-dependent nonspecific protection from reinfection via epigenetic reprogramming of monocytes. Proc. Natl Acad. Sci. USA https:\/\/doi.org\/10.1073\/pnas.1202870109 (2012).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1700_CR28","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1038\/s41586-019-1817-8","volume":"577","author":"PA Darrah","year":"2020","unstructured":"Darrah, P. A. et al. Prevention of tuberculosis in macaques after intravenous BCG immunization. Nature 577, 95\u2013102 (2020).","journal-title":"Nature"},{"key":"1700_CR29","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1016\/j.cell.2020.09.050","volume":"183","author":"SR Leist","year":"2020","unstructured":"Leist, S. R. et al. A mouse-adapted SARS-CoV-2 induces acute lung injury and mortality in standard laboratory mice. Cell 183, 1070\u20131085.e12 (2020).","journal-title":"Cell"},{"key":"1700_CR30","doi-asserted-by":"publisher","first-page":"0023","DOI":"10.1371\/journal.ppat.0030005","volume":"3","author":"A Roberts","year":"2007","unstructured":"Roberts, A. et al. A mouse-adapted SARS-coronavirus causes disease and mortality in BALB\/c mice. PLoS Pathog. 3, 0023\u20130037 (2007).","journal-title":"PLoS Pathog."},{"key":"1700_CR31","doi-asserted-by":"publisher","first-page":"1508","DOI":"10.1038\/nm.3985","volume":"21","author":"VD Menachery","year":"2015","unstructured":"Menachery, V. D. et al. A SARS-like cluster of circulating bat coronaviruses shows potential for human emergence. Nat. Med. 21, 1508\u20131513 (2015).","journal-title":"Nat. Med."},{"key":"1700_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2017.11.034","author":"I Mitroulis","year":"2018","unstructured":"Mitroulis, I. et al. Modulation of myelopoiesis progenitors is an integral component of trained immunity. Cell https:\/\/doi.org\/10.1016\/j.cell.2017.11.034 (2018).","journal-title":"Cell"},{"key":"1700_CR33","doi-asserted-by":"publisher","first-page":"e20190418","DOI":"10.1084\/jem.20190418","volume":"217","author":"M Saraiva","year":"2020","unstructured":"Saraiva, M., Vieira, P. & O\u2019Garra, A. Biology and therapeutic potential of interleukin-10. J. Exp. Med. 217, e20190418 (2020).","journal-title":"J. Exp. Med."},{"key":"1700_CR34","doi-asserted-by":"publisher","first-page":"2806","DOI":"10.3389\/fimmu.2019.02806","volume":"10","author":"C Covi\u00e1n","year":"2019","unstructured":"Covi\u00e1n, C. et al. BCG-induced cross-protection and development of trained immunity: implication for vaccine design. Front. Immunol. 10, 2806 (2019).","journal-title":"Front. Immunol."},{"key":"1700_CR35","doi-asserted-by":"publisher","first-page":"eabl4509","DOI":"10.1126\/sciimmunol.abl4509","volume":"6","author":"B Israelow","year":"2021","unstructured":"Israelow, B. et al. Adaptive immune determinants of viral clearance and protection in mouse models of SARS-CoV-2. Sci. Immunol. 6, eabl4509 (2021).","journal-title":"Sci. Immunol."},{"key":"1700_CR36","doi-asserted-by":"publisher","DOI":"10.1038\/ni.2789","author":"S Li","year":"2014","unstructured":"Li, S. et al. Molecular signatures of antibody responses derived from a systems biology study of five human vaccines. Nat. Immunol. https:\/\/doi.org\/10.1038\/ni.2789 (2014).","journal-title":"Nat. Immunol."},{"key":"1700_CR37","doi-asserted-by":"crossref","first-page":"iyad018","DOI":"10.1093\/genetics\/iyad018","volume":"224","author":"SA Aleksander","year":"2023","unstructured":"Aleksander, S. A. et al. The Gene Ontology knowledge base in 2023. Genetics 224, iyad018 (2023).","journal-title":"Genetics"},{"key":"1700_CR38","doi-asserted-by":"crossref","unstructured":"Ashburner, M. et al. Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat. Genet. 25, 25\u201329 (2000).","DOI":"10.1038\/75556"},{"key":"1700_CR39","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-21246-9","volume":"12","author":"S Jin","year":"2021","unstructured":"Jin, S. et al. Inference and analysis of cell-cell communication using CellChat. Nat. Commun. 12, 1088 (2021).","journal-title":"Nat. Commun."},{"key":"1700_CR40","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1038\/s41587-020-0472-9","volume":"38","author":"CR Merritt","year":"2020","unstructured":"Merritt, C. R. et al. Multiplex digital spatial profiling of proteins and RNA in fixed tissue. Nat. Biotechnol. 38, 586\u2013599 (2020).","journal-title":"Nat. Biotechnol."},{"key":"1700_CR41","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-28197-9","volume":"13","author":"A Lee","year":"2022","unstructured":"Lee, A. et al. A molecular atlas of innate immunity to adjuvanted and live attenuated vaccines, in mice. Nat. Commun. 13, 549 (2022).","journal-title":"Nat. Commun."},{"key":"1700_CR42","first-page":"3915","volume":"184","author":"F Wimmers","year":"2021","unstructured":"Wimmers, F. et al. The single-cell epigenomic and transcriptional landscape of immunity to influenza vaccination. Cell Press 184, 3915\u20133935.e21 (2021).","journal-title":"Cell Press"},{"key":"1700_CR43","doi-asserted-by":"publisher","first-page":"102189","DOI":"10.1016\/j.coi.2022.102189","volume":"77","author":"A Lee","year":"2022","unstructured":"Lee, A., Wimmers, F. & Pulendran, B. Epigenetic adjuvants: durable reprogramming of the innate immune systemsy with adjuvants. Curr. Opin. Immunol. 77, 102189 (2022).","journal-title":"Curr. Opin. Immunol."},{"key":"1700_CR44","doi-asserted-by":"publisher","first-page":"103746","DOI":"10.1016\/j.ebiom.2021.103746","volume":"74","author":"A Singhania","year":"2021","unstructured":"Singhania, A. et al. CD4+CCR6+ T cells dominate the BCG-induced transcriptional signature. eBioMedicine 74, 103746 (2021).","journal-title":"eBioMedicine"},{"key":"1700_CR45","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1126\/science.8456300","volume":"259","author":"DK Dalton","year":"1993","unstructured":"Dalton, D. K. et al. Multiple defects of immune cell function in mice with disrupted interferon-\u03b3 genes. Science 259, 1739\u20131742 (1993).","journal-title":"Science"},{"key":"1700_CR46","doi-asserted-by":"publisher","first-page":"270","DOI":"10.4049\/jimmunol.1200061","volume":"190","author":"AM Green","year":"2013","unstructured":"Green, A. M., DiFazio, R. & Flynn, J. L. IFN-\u03b3 from CD4+ T cells Is essential for host survival and enhances CD8 T cell function during Mycobacterium tuberculosis infection. J. Immunol. 190, 270\u2013277 (2013).","journal-title":"J. Immunol."},{"key":"1700_CR47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fimmu.2018.02061","volume":"9","author":"AJ Lee","year":"2018","unstructured":"Lee, A. J. & Ashkar, A. A. The dual nature of type I and type II interferons. Front. Immunol. 9, 1\u201310 (2018).","journal-title":"Front. Immunol."},{"key":"1700_CR48","doi-asserted-by":"publisher","first-page":"1634","DOI":"10.1016\/j.cell.2018.09.042","volume":"175","author":"Y Yao","year":"2018","unstructured":"Yao, Y. et al. Induction of autonomous memory alveolar macrophages requires T cell help and is critical to trained immunity. Cell 175, 1634\u20131650.e17 (2018).","journal-title":"Cell"},{"key":"1700_CR49","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1038\/s41586-021-03791-x","volume":"596","author":"PS Arunachalam","year":"2021","unstructured":"Arunachalam, P. S. et al. Systems vaccinology of the BNT162b2 mRNA vaccine in humans. Nature 596, 410\u2013416 (2021).","journal-title":"Nature"},{"key":"1700_CR50","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1038\/s41590-022-01163-9","volume":"23","author":"C Li","year":"2022","unstructured":"Li, C. et al. Mechanisms of innate and adaptive immunity to the Pfizer-BioNTech BNT162b2 vaccine. Nat. Immunol. 23, 543\u2013555 (2022).","journal-title":"Nat. Immunol."},{"key":"1700_CR51","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.1126\/science.abc4730","volume":"369","author":"H Gu","year":"2020","unstructured":"Gu, H. et al. Adaptation of SARS-CoV-2 in BALB\/c mice for testing vaccine efficacy. Science 369, 1603\u20131607 (2020).","journal-title":"Science"},{"key":"1700_CR52","doi-asserted-by":"publisher","first-page":"e00276","DOI":"10.1128\/mBio.00276-16","volume":"7","author":"S Stegemann-Koniszewski","year":"2016","unstructured":"Stegemann-Koniszewski, S. et al. Alveolar type II epithelial cells contribute to the anti-influenza A virus response in the lung by integrating pathogen- and microenvironment-derived signals. mBio 7, e00276\u201316 (2016).","journal-title":"mBio"},{"key":"1700_CR53","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/S1074-7613(00)00014-5","volume":"13","author":"S Balachandran","year":"2000","unstructured":"Balachandran, S. et al. Essential role for the dsRNA-dependent protein kinase PKR in innate immunity to viral infection. Immunity 13, 129\u201341 (2000).","journal-title":"Immunity"},{"key":"1700_CR54","first-page":"690","volume":"13","author":"SH Sims","year":"1993","unstructured":"Sims, S. H. et al. A novel interferon-inducible domain: structural and functional analysis of the human interferon regulatory factor 1 gene promoter. Mol. Cell. Biol. 13, 690\u2013702 (1993).","journal-title":"Mol. Cell. Biol."},{"key":"1700_CR55","doi-asserted-by":"publisher","first-page":"15648","DOI":"10.1038\/s41598-021-95157-6","volume":"11","author":"NMGP de Queiroz","year":"2021","unstructured":"de Queiroz, N. M. G. P., Marinho, F. V., de Araujo, A. C. V. S. C., Fahel, J. S. & Oliveira, S. C. MyD88-dependent BCG immunotherapy reduces tumor and regulates tumor microenvironment in bladder cancer murine model. Sci. Rep. 11, 15648 (2021).","journal-title":"Sci. Rep."},{"key":"1700_CR56","doi-asserted-by":"publisher","first-page":"6911","DOI":"10.1016\/j.vaccine.2014.10.041","volume":"32","author":"DA Kaveh","year":"2014","unstructured":"Kaveh, D. A., Carmen Garcia-Pelayo, M. & Hogarth, P. J. Persistent BCG bacilli perpetuate CD4+ T effector memory and optimal protection against tuberculosis. Vaccine 32, 6911\u20136918 (2014).","journal-title":"Vaccine"},{"key":"1700_CR57","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1038\/mt.2015.216","volume":"24","author":"L Zhang","year":"2016","unstructured":"Zhang, L. et al. Variable virulence and efficacy of BCG vaccine strains in mice and correlation with genome polymorphisms. Mol. Ther. 24, 398\u2013405 (2016).","journal-title":"Mol. Ther."},{"key":"1700_CR58","doi-asserted-by":"publisher","first-page":"1718","DOI":"10.1128\/IAI.74.3.1718-1724.2006","volume":"74","author":"AI Castillo-Rodal","year":"2006","unstructured":"Castillo-Rodal, A. I. et al. Mycobacterium bovis BCG substrains confer different levels of protection against Mycobacterium tuberculosis infection in a BALB\/c model of progressive pulmonary tuberculosis. Infect. Immun. 74, 1718\u20131724 (2006).","journal-title":"Infect. Immun."},{"key":"1700_CR59","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1111\/joim.13037","volume":"288","author":"M Kremenovic","year":"2020","unstructured":"Kremenovic, M., Schenk, M. & Lee, D. J. Clinical and molecular insights into BCG immunotherapy for melanoma. J. Intern. Med. 288, 625\u2013640 (2020).","journal-title":"J. Intern. Med."},{"key":"1700_CR60","doi-asserted-by":"publisher","first-page":"100185","DOI":"10.1016\/j.xcrm.2020.100185","volume":"2","author":"MPM Vierboom","year":"2021","unstructured":"Vierboom, M. P. M. et al. Stronger induction of trained immunity by mucosal BCG or MTBVAC vaccination compared to standard intradermal vaccination. Cell Rep. Med. 2, 100185 (2021).","journal-title":"Cell Rep. Med."},{"key":"1700_CR61","doi-asserted-by":"publisher","first-page":"eaaz6606","DOI":"10.1126\/scitranslmed.aaz6606","volume":"12","author":"X Lu","year":"2020","unstructured":"Lu, X. et al. Engineered PLGA microparticles for long-term, pulsatile release of STING agonist for cancer immunotherapy. Sci. Transl. Med. 12, eaaz6606 (2020).","journal-title":"Sci. Transl. Med."},{"key":"1700_CR62","first-page":"399","volume":"386","author":"KD Zens","year":"2015","unstructured":"Zens, K. D. & Farber, D. L. Memory CD4+ T cells in influenza. Curr. Top. Microbiol. Immunol. 386, 399\u2013421 (2015).","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"1700_CR63","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1086\/315347","volume":"181","author":"H Asanuma","year":"1999","unstructured":"Asanuma, H., Sharp, M., Maecker, H. T., Maino, V. C. & Arvin, A. M. Frequencies of memory T cells specific for varicella-zoster virus, herpes simplex virus, and cytomegalovirus by intracellular detection of cytokine expression. J. Infect. Dis. 181, 859\u2013866 (1999).","journal-title":"J. Infect. Dis."},{"key":"1700_CR64","doi-asserted-by":"crossref","unstructured":"Bruxvoort, K. J. et al. Recombinant adjuvanted zoster vaccine and reduced risk of COVID-19 diagnosis and hospitalization in older adults. J. Infect. Dis. 225, 1915\u20131922 (2021).","DOI":"10.1093\/infdis\/jiab633"},{"key":"1700_CR65","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/j.chom.2021.03.009","volume":"29","author":"VV Edara","year":"2021","unstructured":"Edara, V. V. et al. Infection- and vaccine-induced antibody binding and neutralization of the B.1.351 SARS-CoV-2 variant. Cell Host Microbe 29, 516\u2013521.e3 (2021).","journal-title":"Cell Host Microbe"},{"key":"1700_CR66","doi-asserted-by":"publisher","first-page":"e00985","DOI":"10.1128\/JVI.00985-20","volume":"94","author":"A Vanderheiden","year":"2020","unstructured":"Vanderheiden, A. et al. Type I and type III interferons restrict SARS-CoV-2 infection of human airway epithelial cultures. J. Virol. 94, e00985-20 (2020).","journal-title":"J. Virol."},{"key":"1700_CR67","doi-asserted-by":"publisher","unstructured":"Vanderheiden, A. et al. CCR2 signaling restricts SARS-CoV-2 infection. mBio https:\/\/doi.org\/10.1128\/mBio.02749-21 (2021).","DOI":"10.1128\/mBio.02749-21"},{"key":"1700_CR68","doi-asserted-by":"publisher","unstructured":"Feng, Y. et al. Broadly neutralizing antibodies against sarbecoviruses generated by immunization of macaques with an AS03-adjuvanted COVID-19 vaccine. Sci. Transl. Med. https:\/\/doi.org\/10.1126\/scitranslmed.adg74 (2023).","DOI":"10.1126\/scitranslmed.adg74"},{"key":"1700_CR69","doi-asserted-by":"publisher","unstructured":"Szretter, K. J., Balish, A. L. & Katz, J. M. Influenza: propagation, quantification, and storage. Curr. Protoc. Microbiol. https:\/\/doi.org\/10.1002\/0471729256.mc15g01s3 (2006).","DOI":"10.1002\/0471729256.mc15g01s3"},{"key":"1700_CR70","doi-asserted-by":"publisher","first-page":"100244","DOI":"10.1016\/j.xpro.2020.100244","volume":"2","author":"SB Kovacs","year":"2021","unstructured":"Kovacs, S. B., Oh, C., Aachoui, Y. & Miao, E. A. Evaluating cytokine production by flow cytometry using brefeldin A in mice. STAR Protoc. 2, 100244 (2021).","journal-title":"STAR Protoc."},{"key":"1700_CR71","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/978-1-4939-9454-0_5","volume":"1989","author":"FJ Hartmann","year":"2019","unstructured":"Hartmann, F. J. et al. Scalable conjugation and characterization of immunoglobulins with stable mass isotope reporters for single-cell mass cytometry analysis. Methods Mol. Biol. 1989, 55\u201381 (2019).","journal-title":"Methods Mol. Biol."},{"key":"1700_CR72","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1002\/cyto.a.22067","volume":"81A","author":"HG Fienberg","year":"2012","unstructured":"Fienberg, H. G., Simonds, E. F., Fantl, W. J., Nolan, G. P. & Bodenmiller, B. A platinum-based covalent viability reagent for single-cell mass cytometry. Cytometry 81A, 467\u2013475 (2012).","journal-title":"Cytometry"},{"key":"1700_CR73","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1038\/nprot.2015.020","volume":"10","author":"ER Zunder","year":"2015","unstructured":"Zunder, E. R. et al. Palladium-based mass tag cell barcoding with a doublet-filtering scheme and single-cell deconvolution algorithm. Nat. Protoc. 10, 316\u2013333 (2015).","journal-title":"Nat. Protoc."},{"key":"1700_CR74","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1002\/cyto.a.22625","volume":"A87","author":"S Van Gassen","year":"2015","unstructured":"Van Gassen, S. et al. FlowSOM: using self-organizing maps for visualization and interpretation of cytometry data. Cytometry A87, 636\u2013645 (2015).","journal-title":"Cytometry"},{"key":"1700_CR75","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/978-1-4939-7896-0_6","volume":"1799","author":"H Nakano","year":"2018","unstructured":"Nakano, H., Nakano, K. & Cook, D. N. Isolation and purification of epithelial and endothelial cells from mouse lung. Methods Mol. Biol. 1799, 59\u201369 (2018).","journal-title":"Methods Mol. Biol."}],"container-title":["Nature Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41590-023-01700-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41590-023-01700-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41590-023-01700-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,11]],"date-time":"2024-01-11T14:05:43Z","timestamp":1704981943000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41590-023-01700-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,30]]},"references-count":75,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["1700"],"URL":"https:\/\/doi.org\/10.1038\/s41590-023-01700-0","relation":{},"ISSN":["1529-2908","1529-2916"],"issn-type":[{"value":"1529-2908","type":"print"},{"value":"1529-2916","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,30]]},"assertion":[{"value":"19 July 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 November 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 November 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"B.P. has served or is serving on the External Immunology Network of GSK and on the scientific advisory boards of Sanofi, Medicago, CircBio and Boehringer-Ingelheim. R.S.B. serves on the Scientific Advisory Board of Takeda, Vaxart, Inc. and Invivyd, and has collaborations with Janssen Pharmaceuticals, Gilead, Chimerix and Pardes Biosciences. S.R.L. and R.S.B. are listed on a patent for the SARS-CoV-2 MA10 virus (US 11225508 B1, \u2018Mouse-adapted SARS-CoV-2 viruses and methods of use thereof\u2019). G.P.N is a co-founder and stockholder of Ionpath Inc., a co-founder and stockholder of Akoya Biosciences, Inc. and an inventor on patent US9909167., a Scientific Advisory Board member for Akoya Biosciences, Inc., received research grants from Pfizer, Inc., Vaxart, Inc., Celgene, Inc. and Juno Therapeutics, Inc. and is a co-founder of Scale Biosciences Inc. M.S.S. has served in an advisory role for Ocugen, Inc. The remaining authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}